In concordance with our findings, Reshetnyak et al., 2023 [20] found that increased NETs formation namely MPO-DNA complex was more pronounced among thrombotic APLS patients with a poorer prognosis, such as those with multiple aPL antibodies activity and recurrent thrombosis. This evidence concerns the gene FASLG and deep vein thrombosis.